145 related articles for article (PubMed ID: 26722029)
1. In Vitro Validation of Intratumoral Modulation Therapy for Glioblastoma.
Xu HU; Bihari F; Whitehead S; Wong E; Schmid S; Hebb MO
Anticancer Res; 2016 Jan; 36(1):71-80. PubMed ID: 26722029
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
Yamini B; Yu X; Gillespie GY; Kufe DW; Weichselbaum RR
Cancer Res; 2004 Sep; 64(18):6381-4. PubMed ID: 15374943
[TBL] [Abstract][Full Text] [Related]
3. HSP27 knockdown produces synergistic induction of apoptosis by HSP90 and kinase inhibitors in glioblastoma multiforme.
Belkacemi L; Hebb MO
Anticancer Res; 2014 Sep; 34(9):4915-27. PubMed ID: 25202074
[TBL] [Abstract][Full Text] [Related]
4. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.
Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK
Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
6. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
Pérès EA; Gérault AN; Valable S; Roussel S; Toutain J; Divoux D; Guillamo JS; Sanson M; Bernaudin M; Petit E
Oncotarget; 2015 Feb; 6(4):2101-19. PubMed ID: 25544764
[TBL] [Abstract][Full Text] [Related]
7. Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27.
Sang DP; Li RJ; Lan Q
Acta Pharmacol Sin; 2014 Jun; 35(6):832-8. PubMed ID: 24902789
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.
Wong ST; Zhang XQ; Zhuang JT; Chan HL; Li CH; Leung GK
Anticancer Res; 2012 Jul; 32(7):2835-41. PubMed ID: 22753745
[TBL] [Abstract][Full Text] [Related]
9. Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma.
Di Sebastiano AR; Deweyert A; Benoit S; Iredale E; Xu H; De Oliveira C; Wong E; Schmid S; Hebb MO
Sci Rep; 2018 May; 8(1):7301. PubMed ID: 29740075
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
11. Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/β-catenin signaling pathway.
Zhang C; Yang X; Fu C; Liu X
Gene; 2018 Sep; 672():172-179. PubMed ID: 29906532
[TBL] [Abstract][Full Text] [Related]
12. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
[TBL] [Abstract][Full Text] [Related]
13. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
[TBL] [Abstract][Full Text] [Related]
14. Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.
Vartanian A; Agnihotri S; Wilson MR; Burrell KE; Tonge PD; Alamsahebpour A; Jalali S; Taccone MS; Mansouri S; Golbourn B; Aldape KD; Zadeh G
Oncotarget; 2016 Oct; 7(43):69518-69535. PubMed ID: 27588472
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment.
Jakubowicz-Gil J; Langner E; Bądziul D; Wertel I; Rzeski W
Tumour Biol; 2013 Aug; 34(4):2367-78. PubMed ID: 23580181
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract][Full Text] [Related]
17. Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?
Cruickshanks N; Shervington L; Patel R; Munje C; Thakkar D; Shervington A
Cancer Invest; 2010 Jul; 28(6):608-14. PubMed ID: 20210521
[TBL] [Abstract][Full Text] [Related]
18. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment.
Jakubowicz-Gil J; Langner E; Bądziul D; Wertel I; Rzeski W
Toxicol Appl Pharmacol; 2013 Dec; 273(3):580-9. PubMed ID: 24126416
[TBL] [Abstract][Full Text] [Related]
20. Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses.
Le Mercier M; Mathieu V; Haibe-Kains B; Bontempi G; Mijatovic T; Decaestecker C; Kiss R; Lefranc F
J Neuropathol Exp Neurol; 2008 May; 67(5):456-69. PubMed ID: 18431251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
